Parkin and mitochondria

Brain and Nerve

Volumn 60, Issue 8, 2008, Pages 923-929

  Mitsui, Takao ^a   Kuroda, Yukiko ^b   Kaji, Ryuji ^b  

^a Yoshinogawa   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Function; Mitochondria; Pakinson disease; PARK; Parkin

Indexed keywords

DJ 1 PROTEIN; PARKIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME; UBIQUITIN;

AUTOSOMAL RECESSIVE DISORDER; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; FAMILIAL DISEASE; HUMAN; HUMAN CELL; MITOCHONDRION; MUTATION; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN FUNCTION; REVIEW;

HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIA; MUTATION; ONCOGENE PROTEINS; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN KINASES; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 51149106952     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Abou-Sleiman PM, Muqit MM, Wood NW: Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci 7: 207-219, 2006
2. Wood-Kaczmar A, Gandhi S, Wood NW: Understanding the molecular causes of Parkinson's disease. Trends Mol Med 12: 521-528, 2006
3. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, et al: Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306, 2000
4. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, et al: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608, 1998
5. Lücking CB, Dürr A, Bonifati V, Vaughan J, De Michele G, et al: Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 342: 1560-7, 2000
6. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, et al: Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25: 302-305, 2000
7. Mata IF, Lockhart PJ, Farrer MJ: Parkin genetics: one model for Parkinson's disease. Hum Mol Genet 13 (Spec No 1): R127-133, 2004
8. Sakata E, Yamaguchi Y, Kurimoto E, Kikuchi J, Yokoyama S, et al: Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep 4: 301-306, 2003
9. Joazeiro, CAP, Weissman AM: RING finger proteins: mediators of ubiquitin ligase activity. Cell 102: 549-552, 2000
10. Poukka H, Aarnisalo P, Santti H, Jänne OA, Palvimo JJ: Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid receptor-mediated transcription by different mechanisms. J Biol Chem 275: 571-579, 2000
11. Kuroda Y, Mitsui T, Kunishige M, Shono M, Akaike M, et al: Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet 15: 883-895, 2006
12. Zarate-Lagunes M, Gu WJ, Blanchard V, Francois C, Muriel MP, et al: Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in parkinsonian syndromes. J Comp Neurol 432: 184-196, 2001
13. Stichel CC, Augustin M, Kuhn K, Zhu XR, Engels P, et al: Parkin expression in the adult mouse brain. Eur J Neurosci 12: 4181-4194, 2000
14. Shimura H, Hattori N, Kubo S, Yoshikawa M, Kitada T, et al: Immunohistochemical and subcellular localization of parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patient. Ann Neurol 45: 668-672, 1999
15. Kubo S, Kitami T, Noda S, Shimura H, Uchiyama Y, et al: Parkin is associated with cellular vesicles. J Neurochem 78: 42-54, 2001
16. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, et al: Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12: 517-526, 2003
17. Kuroda Y, Mitsui T, Kunishige M, Matsumoto T: Parkin affects mitochondrial function and apoptosis in neuronal and myogenic cells. Biochem Biophys Res Commun 348: 787-793, 2006
18. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, et al: Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279: 18614-18622, 2004
19. Rosen KM, Veereshwarayya V, Moussa CE, Fu Q, Goldberg MS, et al: Parkin protects against mitochondrial toxins and beta-amyloid accumulation in skeletal muscle cells. J Biol Chem 281: 12809-12816, 2006
20. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, et al: Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278: 43628-34365, 2003
21. Perez FA, Palmiter RD: Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci U S A 102: 2174-2179, 2005
22. Casarejos MJ, Menéndez J, Solano RM, Rodríguez-Navarro JA, García de Yébenes J, et al: Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem 97: 934-946, 2006
23. Riparbelli MG, Callaini G: The Drosophila parkin homologue is required for normal mitochondrial dynamics during spermiogenesis. Dev Biol 303: 108-120, 2007
24. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, et al: Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A 100: 4078-4083, 2003
25. Greene JC, Whitworth AJ, Andrews LA, Parker TJ, Pallanck LJ: Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum Mol Genet 14: 799-811, 2005
26. Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, et al: PINK1 protein in normal human brain and Parkinson's disease. Brain 129: 1720-1731, 2006
27. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, et al: Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14: 3477-3492, 2005
28. Sim CH, Lio DS, Mok SS, Masters CL, Hill AF, et al: C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet 15: 3251-3262, 2006
29. Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, et al: Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A 103: 10793-10798, 2006
30. Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, et al: Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441: 1162-1166, 2006
31. Park J, Lee SB, Lee S, Kim Y, Song S, et al: Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441: 1157-1161, 2006
32. Moore DJ: Parkin: a multifaceted ubiquitin ligase. Biochem Soc Trans 34(Pt 5): 749-753, 2006
33. Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, et al: Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet 14: 2063-2073, 2005
34. Xu J, Zhong N, Wang H, Elias JE, Kim CY, et al: The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum Mol Genet. 14: 1231-1241, 2005
35. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP: DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A 103: 15091-15096, 2006
36. Moore DJ, Zhang L, Troncoso J, Lee MK, Hattori N, et al: Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet 14: 71-84, 2005
37. Tang B, Xiong H, Sun P, Zhang Y, Wang D, et al: Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet 15: 1816-1825, 2006
38. Schapira AH: Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol 7: 97-109, 2008
39. Dodson MW, Guo M: Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol 17: 331-337, 2007
40. Smith WW, Pei Z, Jiang H, Moore DJ, Liang Y, et al: Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci U S A 102: 18676-18681, 2005
41. Paciello O, Wójcik S, Engel WK, McFerrin J, Askanas V: Parkin and its association with alpha-synuclein and AbetaPP in inclusion-body myositis and AbetaPP-overexpressing cultured human muscle fibers. Acta Myol 25: 13-22, 2006
42. Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, et al: Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. Proc Natl Acad Sci U S A 101: 17510-17515, 2004
43. Thomas B, Beal MF: Parkinson's disease. Hum Mol Genet 16: R183-194, 2007